Evidence map›Paper›PMID 35771213›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2022

Development of an Allenyne-Alkyne [4+2] Cycloaddition and its Application to Total Synthesis of Selaginpulvilin A.

Anh Le, Saswata Gupta, Man Xu, Yuanzhi Xia, Daesung Lee

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anh LeDepartment of Chemistry, University of Illinois Chicago, 845 West Taylor Street, 60607, Chicago, Illinois, USA.
Saswata GuptaDepartment of Chemistry, University of Illinois Chicago, 845 West Taylor Street, 60607, Chicago, Illinois, USA.ORCID http://orcid.org/0000-0002-4135-0600
Man XuCollege of Chemistry and Materials Engineering, Wenzhou University, 325035, Wenzhou, Zhejiang Province, P. R. China.
Yuanzhi XiaCollege of Chemistry and Materials Engineering, Wenzhou University, 325035, Wenzhou, Zhejiang Province, P. R. China.ORCID http://orcid.org/0000-0003-2459-3296
Daesung LeeDepartment of Chemistry, University of Illinois Chicago, 845 West Taylor Street, 60607, Chicago, Illinois, USA.ORCID http://orcid.org/0000-0003-3958-5475

Funding

National Natural Science Foundation of China 21572163National Natural Science Foundation of China 21873074National Science Foundation 2055055
6 · The paper itself

Abstract

A new [4+2] cycloaddition of allenyne-alkyne is developed. The reaction is believed to proceed with forming an α,3-dehydrotoluene intermediate. This species behaves as a σπ-diradical to react with a hydrogen atom donor, whereas it displays a zwitterionic reactivity toward weak nucleophiles. The efficiency of trapping α,3-dehydrotoluene depends not only on its substituents but also the trapping agents. Notable features of the reaction are the activating role of the extra alkyne of the 1,3-diyne that reacts with the allenyne moiety and the opposite mode of trapping with oxygen and nitrogen nucleophiles. Oxygen nucleophiles result in the oxygen-end incorporation at the benzylic position of the α,3-dehydrotoluene, whereas with amine nucleophiles the nitrogen-end is incorporated into the aromatic core. Relying on the allenyne-alkyne cycloaddition as an enabling strategy, a concise total synthesis of phosphodiesterase-4 inhibitory selaginpulvilin A is realized.

Indexed as

AlkynesCyclic Nucleotide Phosphodiesterases, Type 4AminesCycloaddition ReactionDiynesHydrogenNitrogenOxygenAlkynesAminesCyclic Nucleotide Phosphodiesterases, Type 4DiynesHydrogenNitrogenOxygenallenynecycloadditioncycloaromatizationselaginpuvilin Aα,3-dehydrotoluene

Identifiers

PMID35771213
PMCPMC9805236

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.